Both in Biotechnology
SAB Biotherapeutics vs Ocugen
Over the past year SABS returned +6.0% and OCGN returned −48.9%; their daily moves had a correlation of 0.30.
SABS +6.0% OCGN −48.9%Growth of $1, one year, split-adjusted
| Metric | SABS | OCGN |
|---|---|---|
| Price | $3.16 | $0.7551 |
| Market cap | $287.1M | $256.1M |
| Today | +2.77% | −0.30% |
| 1 month | −2.0% | −30.7% |
| 6 months | −9.3% | −55.1% |
| Year to date | −15.6% | −44.1% |
| 1 year | +4.1% | −51.6% |
| Revenue growth (YoY) | — | +8.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1671.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $99.4M | $15.9M |
| Dividend yield | — | — |
| Volatility (60d) | 55.0% | 69.9% |
| Short % of float | 6.2% | 33.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).